Skip to content

Insider · CIK 0001618364

William Garrett Nichols

officer

Files at CADL (Candel Therapeutics, Inc.). First filing Dec 3, 2024, latest Mar 20, 2025.

Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
0 / 4
$0 bought, $625k sold

Where the trades landed

Last year at the company this insider has traded most, with each buy and sell on the bar it happened.

CADL: Candel Therapeutics, Inc.

CADLOct 9, 2026 · close 9.94

Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™

Signals

This insider’s open-market buys and sells, scored.

ScoreCompanyValueHoldingsPrice contextFiled
21Weak
CADLsell 510b5-1
Candel Therapeutics, Inc.
$397k
45,316 shares
-46%+132% from low-28% from high
43Moderate
CADLsell 5
Candel Therapeutics, Inc.
$75k
10,428 shares
-12%+111% from low-20% from high
44Moderate
CADLsell 5
Candel Therapeutics, Inc.
$89k
10,799 shares
-11%+130% from low-12% from high
43Moderate
CADLsell 4
Candel Therapeutics, Inc.
$63k
13,935 shares
-12%-

Transactions

Every row this insider has filed, newest first.

DateCompanyTransactionSharesPriceValueHoldings afterFiled
Mar 18, 2025CADL
Candel Therapeutics, Inc.
MOption exercise
Common Stock10b5-1
+4,584$3.75$17k83,904Mar 20, 2025
Mar 18, 2025CADL
Candel Therapeutics, Inc.
MOption exercise
Common Stock10b5-1
+13,905$1.29$18k97,809Mar 20, 2025
Mar 18, 2025CADL
Candel Therapeutics, Inc.
SOpen-market sale
Common Stock10b5-1
-45,316$8.76$397k52,493Mar 20, 2025
Mar 18, 2025CADL
Candel Therapeutics, Inc.
MOption exercise
Stock Option (Right to Buy)derivative10b5-1
-4,584$0.00$0195,416Mar 20, 2025
Mar 18, 2025CADL
Candel Therapeutics, Inc.
MOption exercise
Stock Option (Right to Buy)derivative10b5-1
-13,905$0.00$031,095Mar 20, 2025
Feb 12, 2025CADL
Candel Therapeutics, Inc.
AGrant or award
Stock Option (Right to Buy)derivative
+107,250$0.00$0107,250Feb 14, 2025
Jan 15, 2025CADL
Candel Therapeutics, Inc.
SOpen-market sale
Common Stock
-10,428$7.23$75k79,320Jan 17, 2025
Jan 8, 2025CADL
Candel Therapeutics, Inc.
SOpen-market sale
Common Stock
-10,799$8.22$89k89,748Jan 10, 2025
Nov 29, 2024CADL
Candel Therapeutics, Inc.
SOpen-market sale
Common Stock
-13,935$4.56$63k100,547Dec 3, 2024

Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.

William Garrett Nichols: insider trades and track record | InsiderTell